Clinical Trial: This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis

U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364487) titled 'This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis' on Jan. 13.

Brief Summary: This is an open-label,early-stage exploratory clinical study to evaluate the safety and preliminary efficacy of GC012F CAR T cell injection in Multiple Sclerosis subjects.

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Multiple Sclerosis

Intervention: DRUG: GC012F CAR-T Cell Injection

A single dose group is planned for the CAR-T cell infusion dose is administrated for each subject.Single IV infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Huashan Hospital

Informat...